Genomic study via chromosomal microarray analysis in a group of Romanian patients with obesity and developmental disability/intellectual disability

J Pediatr Endocrinol Metab. 2019 Jul 26;32(7):667-674. doi: 10.1515/jpem-2018-0439.

Abstract

Background Obesity with developmental disability/intellectual disability (DD/ID) is the most common association in syndromic obesity. Genomic analysis studies have allowed the decipherment of disease aetiology, both in cases of syndromic obesity as well as in cases of isolated or syndromic DD/ID. However, more data are needed to further elucidate the link between the two. The aim of this pangenomic study was to use single nucleotide polymorphism (SNP) array technology to determine the copy number variant (CNV) type and frequency associated with both obesity and DD/ID. Methods Thirty-six patients were recruited from the Clinical Emergency Hospital for Children, in Cluj-Napoca, Romania during the period 2015-2017. The main inclusion criterion was a diagnosis that included both obesity and DD/ID. Genomic analysis via SNP array technology was performed. Results Out of the 36 patients, 12 (33%) presented CNVs with a higher degree of pathogenicity (A group) and 24 (66%) presented benign CNVs (B group). The SNP array results for the A group were as follows: pathogenic CNVs in 8/12 patients (67%); variants of unknown significance (VOUS) in 2/12 patients (16%); and uniparental disomy (UPD) in 2/12 patients (16%). Conclusions Some of these CNVs have already been observed in patients with both obesity and DD/ID, but the others were noticed only in DD/ID patients and have not been described until now in association with obesity.

Keywords: copy number variants; developmental disability/intellectual disability; obesity.

MeSH terms

  • Adolescent
  • Biomarkers / analysis*
  • Child
  • Child, Preschool
  • Chromosome Aberrations*
  • DNA Copy Number Variations
  • Developmental Disabilities / complications
  • Developmental Disabilities / epidemiology
  • Developmental Disabilities / genetics*
  • Developmental Disabilities / pathology
  • Female
  • Follow-Up Studies
  • Genetic Testing
  • Genomics / methods*
  • Humans
  • Infant
  • Intellectual Disability / complications
  • Intellectual Disability / epidemiology
  • Intellectual Disability / genetics*
  • Intellectual Disability / pathology
  • Male
  • Microarray Analysis
  • Pediatric Obesity / complications
  • Pediatric Obesity / epidemiology
  • Pediatric Obesity / genetics*
  • Pediatric Obesity / pathology
  • Polymorphism, Single Nucleotide*
  • Prognosis
  • Romania / epidemiology

Substances

  • Biomarkers